Clinical Trial Result Information

Protocol number
BM18106

Title of Study
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Sponsor
Hoffmann-La Roche

Company division
Pharmaceutical

Product name
DPP-IV Inhibitor

Therapeutic area
Diabetes Mellitus, Type 2

Clinical study summary
No data will be posted since Roche made a strategic decision to terminate the project. The decision was based on available clinical data, indicating that the compound does not provide enough clinical differentiation from other anti-diabetic therapy currently available, and was not due to an unacceptable safety profile .

Phase of development
II

Date of report
6/22/2007

Click here for the protocol registry listing of this trial.